期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Occlusive Syndrome Revealing a Nonseminoma Germ Cell Tumor Metastatic Testicular
1
作者 N. M. Diagne Gueye R. Kane +2 位作者 Y. Diallo A. R. Ndiaye A. R. Ndiaye 《Open Journal of Urology》 2016年第9期147-153,共7页
Testicular cancer is rare. The authors report the case of a young Senegalese 21, who has consulted for an occlusive syndrome evolving for 48 hours that prompted his hospitalization. Note that the patient has consulted... Testicular cancer is rare. The authors report the case of a young Senegalese 21, who has consulted for an occlusive syndrome evolving for 48 hours that prompted his hospitalization. Note that the patient has consulted several times to persistent inguinal scrotal pain, a big right purse with chronic analgesic requirements and anti-inflammatory. Occlusive before this table, abdominal pelvic CT was performed and highlighted the presence of lung metastases, a large pelvic lymph node casting bridging the inter vesico-rectal space and responsible for extrinsic compression of the small intestine, lymph node inter casting aorto-cellar and latero aortic liver and multiple secondary locations. Faced with this bundle of arguments, clinical and laboratory, metastatic testicular tumor was raised and measured tumor markers. A right orchiectomy by inguinal was made with histology: A non-seminomatous germ cell tumor stage III. After orchiectomy germinal markers were still high and there was the problem of persistent occlusive syndrome despite resuscitation. A chemotherapy regimen was initiated with 4 cycles of chemotherapy according to the protocol BEP (bleomycin, etoposide, cisplatin). A significant regression of occlusive syndrome with a decline in clinical symptoms was noted. The revaluation at 3 months, 6 months and 1 year were highlighted: A normal clinical examination associated with a persistent correction rate of germline markers and lack of active lesion at thoraco-abdominopelvic CT. 展开更多
关键词 Testicular Cancer non seminomatous germ cell tumor Intestinal Obstruction
下载PDF
Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor:A tertiary care experience
2
作者 Dario Franzese Antonio Tufano +11 位作者 Alessandro Izzo Raffaele Muscariello Giovanni Grimaldi Giuseppe Quarto Luigi Castaldo Sabrina Rossetti Savio Domenico Pandolfo Sonia Desicato Paola Del Prete Matteo Ferro Sandro Pignata Sisto Perdonà 《Asian Journal of Urology》 CSCD 2023年第4期440-445,共6页
Objective Post-chemotherapy retroperitoneal lymph node dissection(PC-RPLND)represents an integral component of the management of patients with non-seminomatous germ cell tumor(NSGCT).Modified templates have been propo... Objective Post-chemotherapy retroperitoneal lymph node dissection(PC-RPLND)represents an integral component of the management of patients with non-seminomatous germ cell tumor(NSGCT).Modified templates have been proposed to minimize the surgical morbidity of the procedure.Moreover,the implementation of robotic surgery in this setting has been explored.We report our experience with unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection(PC-rRPLND)for clinical Stages IIA and IIB NSGCTs.Methods A retrospective single institution review was performed including 33 patients undergoing PC-rRPLND for Stages IIA and IIB NSGCTs between January 2015 and February 2019.Following orchiectomy,patients were scheduled for chemotherapy with three cycles of bleomycin-etoposide-cisplatin.Patients with a residual tumor of<5 cm and an ipsilateral metastatic disease on pre-and post-chemotherapy CT scans were eligible for a unilateral template in absence of rising tumor markers.Descriptive statistics were provided for demographics,clinical characteristics,intraoperative and postoperative parameters.Perioperative,oncological,and functional outcomes were recorded.Results Overall,7(21.2%)patients exhibited necrosis or fibrosis;14(42.4%)had mature teratoma;and 12(36.4%)had viable tumor at final histology.The median lymph node size at surgery was 25(interquartile range[IQR]21-36)mm.Median operative time was 180(IQR 165-215)min and no major postoperative complications were observed.Anterograde ejaculation was preserved in 75.8%of patients.Median follow-up was 26(IQR 19-30)months and a total of three recurrences were recorded.Conclusion PC-rRPLND is a reliable and technically reproducible procedure with safe oncological outcomes and acceptable postoperative ejaculatory function in well selected patients with NSGCTs. 展开更多
关键词 Testis tumor Robot-assisted retroperitoneal lymph node dissection Retroperitoneal lymph node dissection non-seminomatous germ cell tumor Unilateral dissection Modified template Post-chemotherapy
下载PDF
腹腔镜腹膜后淋巴结清扫术治疗临床Ⅰ-Ⅱ期睾丸非精原细胞瘤的疗效观察 被引量:3
3
作者 李兵兵 顾朝辉 +6 位作者 贾占奎 李文波 丁映辉 黄珍林 马中立 王展 杨锦建 《临床泌尿外科杂志》 2015年第9期801-803,共3页
目的:探讨腹腔镜腹膜后淋巴结清扫术治疗临床Ⅰ-Ⅱ(a/b)期睾丸非精原细胞瘤的疗效。方法:2012年8月2014年6月采用腹腔镜腹膜后淋巴结清扫术治疗睾丸非精原细胞瘤患者7例,观察并统计手术时间、术中出血量、淋巴结清扫个数、术后胃肠... 目的:探讨腹腔镜腹膜后淋巴结清扫术治疗临床Ⅰ-Ⅱ(a/b)期睾丸非精原细胞瘤的疗效。方法:2012年8月2014年6月采用腹腔镜腹膜后淋巴结清扫术治疗睾丸非精原细胞瘤患者7例,观察并统计手术时间、术中出血量、淋巴结清扫个数、术后胃肠功能恢复时间、术后住院时间及并发症发生情况。结果:所有患者手术顺利,均未改行开放手术。手术时间(189±35)min,术中出血量(71±12)ml,淋巴结清扫(16±5)个,术后胃肠功能恢复时间(2.5±0.5)d,术后住院(8±2)d。术后所有患者恢复良好,性功能正常,肿瘤未现局部复发及远处转移。结论:腹腔镜腹膜后淋巴结清扫术具有安全、高效、创伤小、恢复快等特点,对临床Ⅰ-Ⅱ(a/b)期睾丸非精原细胞瘤有较好疗效。 展开更多
关键词 睾丸肿瘤 非精原细胞瘤 腹腔镜术 腹膜后淋巴结清扫术
原文传递
Ⅲb期睾丸非精原细胞瘤综合治疗1例并文献复习 被引量:2
4
作者 陈金波 祖雄兵 +1 位作者 齐琳 陈敏丰 《中华男科学杂志》 CAS CSCD 2014年第3期263-266,共4页
目的:探讨以BEP方案(顺铂、依托泊苷、博来霉素)化疗和腹腔镜下保留神经的腹膜后淋巴结清扫术(nsLRPLND)为基础的综合疗法治疗临床Ⅲb期睾丸非精原细胞瘤(NSGCT)的临床经验。方法:回顾性报告1例Ⅲb期睾丸NSGCT的临床资料及治疗方法,结... 目的:探讨以BEP方案(顺铂、依托泊苷、博来霉素)化疗和腹腔镜下保留神经的腹膜后淋巴结清扫术(nsLRPLND)为基础的综合疗法治疗临床Ⅲb期睾丸非精原细胞瘤(NSGCT)的临床经验。方法:回顾性报告1例Ⅲb期睾丸NSGCT的临床资料及治疗方法,结合文献进行讨论。结果:化疗顺利,手术成功,围手术期无明显并发症,手术用时175min,术中出血50ml。术后随访6个月,肿瘤无局部复发及远处转移。结论:以BEP方案化疗和nsLRPLND为基础的综合疗法可能成为治疗临床Ⅲb期睾丸NSGCT的方法之一。 展开更多
关键词 综合治疗 BEP化疗 腹腔镜下保留神经的腹膜后淋巴结清扫术 Ⅲb期睾丸非精原细胞瘤
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部